Otello Stampacchia

Managing Director
Omega Funds

Otello is a pioneering leader in life sciences investment with over two decades of experience driving transformative advancements in healthcare. He founded Omega Funds in 2003, and currently leads the firm’s investor relations and strategic initiatives. He is a member of the firm’s investment committee and is also heavily involved in several of Omega’s therapeutic areas of interest, particularly oncology and inflammatory disorders.

Previously, Otello oversaw life sciences direct investments as well as diligence for healthcare venture fund of fund investments at AlpInvest Partners, one of the largest private equity asset managers worldwide. Before AlpInvest, he was the portfolio manager of the Lombard Odier Immunology Fund, a $3 billion listed investment vehicle in Geneva, Switzerland, investing in public and private healthcare companies worldwide. Otello was also a member of the HealthCare corporate finance and M&A team at Goldman Sachs. Before Goldman, he helped co-found the healthcare investment activities at Index Securities (now Index Ventures).

Otello has a PhD in Molecular Biology from the University of Geneva, holds a European Doctorate in Biotechnology from the EU, and obtained an MSc in Genetics from the University of Pavia.